induction of labor. Single spontaneous delivery
Conditions
Interventions
Intervention 1: Group 1: A suppository of Prostaglandin E2 (3mg,), Oxytocine (High Dose, with 6MIU starts and every 20 minutes if needed to be added to eight drops of up to 64 drops can be increased).
Treatment - Drugs
Group 1: A suppository of Prostaglandin E2 (3mg,), Oxytocine (High Dose, with 6MIU starts and every 20 minutes if needed to be added to eight drops of up to 64 drops can be increased).
Group 2: A Foley catheter of No. 16, Oxytocine (High Dose, with 6MIU starts and every 20 minutes if needed to be added to eight drops of up to 64 drops can be increased).
Sponsors
Vice Chancellor for Research and Technology, Babol University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: Term pregnant women (37-42 weeks), first pregnancy that had indication of labor and Bishop Score less than 5. Exclusion criteria: Rupture of membrane, Twin pregnancy, Preterm labor and closed cervix.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preinduction cervical ripening. Timepoint: 12 to 48 hours after intervention. Method of measurement: Clinical examinations. | — |
Secondary
| Measure | Time frame |
|---|---|
| Use of induction. Timepoint: 12 to 48 hours after entries. Method of measurement: Clinical examinations.;Type of delivery. Timepoint: 12 to 48 hours after entries. Method of measurement: Clinical examinations.;Infant status. Timepoint: 12 to 48 hours after entries. Method of measurement: Clinical examinations.;Possible complication. Timepoint: 12 to 48 hours after entries. Method of measurement: Clinical examinations. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNargess Gholizadeh Pasha
Fatemehzahra Fertility & reproductive Health Research Center
Outcome results
None listed